Published in Vaccine Weekly, May 9th, 2001
Gastroenterologist M. Angelico and colleagues at the University of Rome Tor Vergata reported their findings at the 36th annual meeting of the European Association for the Study of the Liver (EASL), held April 18-22, 2001, in Prague, Czech Republic. Their study is titled "Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis."
Angelico et al. wrote in their EASL conference abstract: ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.